跳至主要内容
临床试验/IRCT20220903055861N1
IRCT20220903055861N1尚未招募2 期

The comparison between high dose suppository Diclofenac and Pethidine in post cesarean section pain relief

Alborz University of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 45 years(—)
性别
Female

入选标准

  • Full-term Pregnant women
  • Aside C-section indication
  • Full-term alive neonate
  • Age between 18 and 45 year
  • Participation consent

排除标准

  • Patients who show an allergic reaction to the drug will be excluded from the study
  • History of allergy to NSAID and pethidine
  • Bronchial asthma
  • Drug addiction, alcohol abuse, opium addict or the use of any drug that impairs the perception of pain
  • Coagulopathy
  • Gastrointestinal tract ulcers, stomach ulcers, history of gastrointestinal bleeding
  • Long-term steroid treatment or continuous use of painkillers
  • Neurological or psychological disorders
  • Users of medications that interact with pethidine, such as MAO inhibitors (e.g., isocarboxazid , methylene blue, linezolid), certain pain medications (e.g., pentazocine, nalbuphine, butorphanol), seizure medications (e.g., carbamazepine, phenytoin)
  • Liver and kidney diseases

研究者

发起方
Alborz University of Medical Sciences

相似试验

The comparison between high dose suppository... | 临床试验